Who is sponsoring NCT03787810?

NCT03787810 is sponsored by Sahlgrenska University Hospital.

What drugs are being tested in NCT03787810?

Interventions in NCT03787810: Echocardiography.

What condition does NCT03787810 study?

NCT03787810 studies Left Ventricular Dysfunction, Critically Ill, Acute Coronary Syndrome, Cardiomyopathies, Takotsubo Cardiomyopathy.

Is NCT03787810 still recruiting?

NCT03787810 is currently completed. Last updated 24 April 2020.

Last reviewed 2020-04-24 · How we verify

NCT03787810: LEVEDYCIP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Left Ventricular Dysfunction in Critically Ill Patients

Completed Last updated 24 April 2020

What this trial tests

trial testing Echocardiography in Left Ventricular Dysfunction in 428 participants. Completed in 20 February 2020.

Timeline

28 May 2018

Primary endpoint
20 February 2019

20 February 2020

Quick facts

Lead sponsor	Sahlgrenska University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	428
Start date	28 May 2018
Primary completion	20 February 2019
Estimated completion	20 February 2020
Sites	1 location across Sweden

Drugs / interventions tested

Echocardiography

Conditions studied

Left Ventricular Dysfunction — all drugs for Left Ventricular Dysfunction →
Critically Ill — all drugs for Critically Ill →
Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Cardiomyopathies — all drugs for Cardiomyopathies →

Sponsor

Sahlgrenska University Hospital

Who can join

18 and older, any sex, with Left Ventricular Dysfunction or Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Left ventricular dysfunction is common in the critically ill. The aim of this study is to assess the incidence and prognosis of left ventricular dysfunction in critically ill patients.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Regional left ventricular systolic dysfunction associated with critical illness: incidence and effect on outcome.
Cavefors O, Holmqvist J, Bech-Hanssen O, Einarsson F, et al · · 2021 · cited 16× · PMID 34605611 · DOI 10.1002/ehf2.13633
ESICM LIVES 2020.
· 2020 · cited 13× · PMID 33313986 · DOI 10.1186/s40635-020-00354-8
ESICM LIVES 2019 : Berlin, Germany. 28 September - 2 October 2019.
· 2019 · cited 8× · PMID 31559498 · DOI 10.1186/s40635-019-0265-y
Isolated diastolic dysfunction is associated with increased mortality in critically ill patients.
Cavefors O, Ljung Faxén U, Bech-Hanssen O, Lundin S, et al · · 2023 · cited 7× · PMID 36947970 · DOI 10.1016/j.jcrc.2023.154290
Cardiac biomarkers for screening and prognostication of cardiac dysfunction in critically ill patients.
Cavefors O, Einarsson F, Holmqvist J, Bech-Hanssen O, et al · · 2024 · cited 2× · PMID 39087599 · DOI 10.1002/ehf2.14980

Verify or expand the search:

Other trials of Echocardiography

Trials testing the same drug.

NCT06863402 — Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype · Phase 2 · recruiting
NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
NCT06434064 — Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advan · Phase 2 · recruiting
NCT06871410 — Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · Phase 1 · recruiting
NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting

Other recruiting trials for Left Ventricular Dysfunction

Currently open trials in the same condition.

NCT05760924 — Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders · NA · recruiting
NCT06356727 — Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling · NA · recruiting
NCT05769036 — Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients · NA · recruiting
NCT05989945 — HIDRAdenitis Suppurativa and HEART Disease · active not recruiting
NCT05764057 — DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction · Phase 3 · recruiting

Other Sahlgrenska University Hospital trials

Trials by the same sponsor.

NCT07491094 — Repeated Examinations for Typing Pulmonary Embolism · recruiting
NCT07524608 — Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Pa · not yet recruiting
NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
NCT06896578 — Latitude - Lateral Lymph Node Attitude Study · NA · not yet recruiting
NCT07035600 — Walking and Sitting Difficulties After Rectal Cancer Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03787810 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sahlgrenska University Hospital
Last refreshed: 24 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03787810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing